In this population, moderate to severe anxiety is common, highlighting the intersection of infectious disease and mental ...

Surrozen is discontinuing its sole clinical-stage candidate and pivoting to its preclinical ophthalmology pipeline after the ...

Surrozen is dropping its sole clinical asset after the drug failed at Phase I ... is being discontinued in severe alcohol-associated hepatitis. The therapy was under evaluation in two Phase ...